Literature DB >> 857245

Sedative action of low doses of dopaminergic agents.

J Maj, B Przewlocka, L Kukulka.   

Abstract

The activity of rats receiving low doses of dopaminergic agonists and neuroleptics was tested in the "open-field" test. Apomorphine, piribedil, L-DOPA, and nomifensine given at low doses (1-500 mug/ig) depressed the activity of animals. Spiperone and chlorpromazine given at low doses increased the activity, particularly in respect of one of the parameters investigated: the time of walking. Low doses of pimozide, haloperidol, and fluphenazine did not affect measurably the animal behavior. Spiperone counteracted the sedation induced by low doses of apomorphine, piribedil, and nomifensine. Chlorpromazine prevented the sedation produced by apomorphine. In the rats with a lesion of the substantia nigra only nomifensine retained its sedative action, while apomorphine and piribedil ceased to produce it. The reported results further support the hypothesis about the existence and the role of dopaminergic autoreceptors.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 857245

Source DB:  PubMed          Journal:  Pol J Pharmacol Pharm        ISSN: 0301-0244


  4 in total

1.  (+)-UH 232 and (+)-UH 242: novel stereoselective dopamine receptor antagonists with preferential action on autoreceptors.

Authors:  K Svensson; S Hjorth; D Clark; A Carlsson; H Wikström; B Andersson; D Sanchez; A M Johansson; L E Arvidsson; U Hacksell
Journal:  J Neural Transm       Date:  1986       Impact factor: 3.575

2.  Effects of acute or chronic administration of low doses of a dopamine agonist on drinking and locomotor activity in the rat.

Authors:  C T Dourish; S J Cooper
Journal:  Psychopharmacology (Berl)       Date:  1981       Impact factor: 4.530

3.  Nomifensine: A review of its pharmacological properties and therapeutic efficacy in depressive illness.

Authors:  R N Brogden; R C Heel; T M Speight; G S Avery
Journal:  Drugs       Date:  1979-07       Impact factor: 9.546

4.  Three classes of dopamine receptor (D-2, D-3, D-4) identified by binding studies with 3H-apomorphine and 3H-domperidone.

Authors:  P Sokoloff; M P Martres; J C Schwartz
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1980       Impact factor: 3.000

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.